Dataset Information

Murine kidney glomeruli phosphorylation

ABSTRACT: Isolated murine kidney glomeruli were lysed in buffer containing 8M urea, and proteins were reduced and alkylated. Proteins were digested with trypsin. After reverse-phase chomatrography, peptides were fractionated using strong cation exchange chromatography. Phosphopeptides were enriched using IMAC (FeNTA) columns. Peptides were analyzed by LC-MS/MS on a Q Exactive mass spectrometer or an LTQ Orbitrap XL mass spectrometer. Metadata for Orbitrap samples (MaxQuant Output files include „Orbi“) 1. General features – 1.1 Global descriptors a. Responsible person or role: Markus Rinschen. markus.rinschen@uk-koeln.de; tobias.lamkemeyer@uni-koeln.de b. Instrument manufacturer, model: LTQ-Orbitrap XL, Thermo Scientific c. customization 2. Ion sources – ESI fed by nLC 2 (Proxeon) 3. Post source component 3.1. Analyser: MS1 survey scan in an Orbitrap and MS2 analysed in Linear Trap. 3.2. Activation/Dissociation: CID 4. Spectrum and peak list generation and annotation 4.1. Data acquisition: MaxQuant v. 1.3.05 Top one method with a cycle of one full MS1 scan in the Orbitrap, followed by the fragmentation with dynamic exclusion window of 60 seconds and followed by the acquisition of 5 product ion scans generated in the LTQ analyser, and detected in the LTQ. Unselected fragmentation. For further details, see .raw files. URL of file: Filename 4.2. Data analysis: MaxQuant v 1.3.05 Parameters used in the generation of peak lists or processed spectra: see annotation in “parameters” file. The mouse uniprot reference database “complete proteome” obtained on January 2nd, 2013 was used. Metadata for QExactive samples (Max Quant output files include „QE“) 1. General features – 1.1 Global descriptors a. Responsible person or role: Markus Rinschen. markus.rinschen@uk-koeln.de; Marcus Krüger marcus.krueger@mpi-bn.mpg.de b. Instrument manufacturer, model: Q Exactive Thermo Scientific c. customization 2. Ion sources – ESI fed by nLC 1000 (Proxeon) 3. Post source component 3.1. Analyser: MS1 survey scan in an Orbitrap and MS2 analysed in Orbitrap/HCD cell 3.2. Activation/Dissociation: HCD 4. Spectrum and peak list generation and annotation 4.1. Data acquisition: MaxQuant v. 1.3.05 Top one method with a cycle of one full MS1 scan in the Orbitrap, followed by the fragmentation with dynamic exclusion window of 20 seconds in the HCD cell and followed by the acquisition of 10 product ion scans generated in the LTQ analyser, and detected in the LTQ. Unselected fragmentation. For further details, see .raw files. URL of file: Filename 4.2. Data analysis: MaxQuant v 1.3.05 Parameters used in the generation of peak lists or processed spectra: see annotation in “parameters” file. The mouse uniprot reference database “complete proteome” obtained on January 2nd, 2013 was used.

INSTRUMENT(S): LTQ Orbitrap, Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Renal Glomerulus

SUBMITTER: Markus Rinschen

LAB HEAD: Thomas Benzing

PROVIDER: PXD000266 | Pride | 2016-05-09

REPOSITORIES: Pride

ACCESS DATA

Publications

Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier.

Rinschen Markus M MM Wu Xiongwu X König Tim T Pisitkun Trairak T Hagmann Henning H Pahmeyer Caroline C Lamkemeyer Tobias T Kohli Priyanka P Schnell Nicole N Schermer Bernhard B Dryer Stuart S Brooks Bernard R BR Beltrao Pedro P Krueger Marcus M Brinkkoetter Paul T PT Benzing Thomas T

Journal of the American Society of Nephrology : JASN 20140207 7

Diseases of the kidney filtration barrier are a leading cause of ESRD. Most disorders affect the podocytes, polarized cells with a limited capacity for self-renewal that require tightly controlled signaling to maintain their integrity, viability, and function. Here, we provide an atlas of in vivo phosphorylated, glomerulus-expressed proteins, including podocyte-specific gene products, identified in an unbiased tandem mass spectrometry-based approach. We discovered 2449 phosphorylated proteins co ...[more]

PMID: 24511133

Similar Datasets

Project description:Pilotexp_IMAC_TiO2_eluate_ATM_ATR_dep_phos_15min_postIR: Proteins were isolated from 4 different conditions of Arabidopsis thaliana plants: wild type untreated, wild type irradiated, atm/atr mutant untreated, atm/atr mutant irradiated The proteins were tryptically digested and labelled each with one channel ofthe iTRAQ4plex reagent. The samples were mixed and subjected to phosphopeptide enrichment by IMAC followed by TiO2. The enriched phosphopeptides were separated by SCX and each fraction was analysed by nano-reversed phase HPLC coupled online to a LTQ Orbitrap Velos. Each peptide was fragmented both by CID (MSA) and HCD, using the iontrap-MS analyser for CID and the Orbitrap detector for HCD scans. IMAC_TiO2_eluate_ATM_ATR_dep_phos_15min_postIR: Proteins were isolated from 4 different conditions of Arabidopsis thaliana plants: wild type untreated, wild type irradiated, atm/atr mutant untreated, atm/atr mutant irradiated The proteins were tryptically digested and labelled each with one channel ofthe iTRAQ4plex reagent. The samples were mixed and subjected to phosphopeptide enrichment by IMAC followed by TiO2. The enriched phosphopeptides were separated by SCX and each fraction was analysed by nano-reversed phase HPLC coupled online to a LTQ Orbitrap Velos. Each peptide was fragmented both by CID (MSA) and HCD, using the iontrap-MS analyser for CID and the Orbitrap detector for HCD scans. IMAC_TiO2_FT_ATM_ATR_dep_phos_15min_postIR: Proteins were isolated from 4 different conditions of Arabidopsis thaliana plants: wild type untreated, wild type irradiated, atm/atr mutant untreated, atm/atr mutant irradiated The proteins were tryptically digested and labelled each with one channel ofthe iTRAQ4plex reagent. The samples were mixed and subjected to phosphopeptide enrichment by IMAC followed by TiO2. The unphosphorylated peptides found in the flowthrough of the TiO2 column were separated by SCX and each fraction was analysed by nano-reversed phase HPLC coupled online to a LTQ Orbitrap Velos. Each peptide was fragmented both by CID and HCD, using the iontrap-MS analyser for CID and the Orbitrap detector for HCD scans. The iTRAQ ratio obtained for the unmodified peptides from this flowthrough sample was used to calculate protein ratios for the 4 different conditions.

Project description:This dataset derives from experiments testing quantitation using label-free methods. We used the Sigma-Aldrich UPS1 and UPS2 protein standard sets, containing proteins of 6-83 kD; the UPS1 set includes 49 human proteins at a single molar concentration, while the UPS2 set includes six groups of eight human proteins spanning a six orders of magnitude in concentration. In both cases, dilutions of UPS1 or UPS2 proteins were made into an E. coli extract, which allows these experiments to mimic detection of low abundance proteins in a complex protein mixture. The UPS1/E. coli and UPS2/E. coli mixtures were run on three mass spectrometers, an Orbitrap Velos Elite and two ion-trap instruments (Velos and LTQ). Proteins were quantified using MS1 peak volume (Orbitrap) or MS2 intensities and spectral counts (Orbitrap, Velos, LTQ). The analyzed results show that the ion-trap instruments perform nearly as well for label-free quantitation as does the Orbitrap. In addition, the \"Top 3\" method for quantitation—measuring only the three most abundant peptides—performed no better than the \"iBAQ\" quantitation method. Data analysis: MS1 data were analyzed using MaxQuant. MaxQuant version 1.2.2.5 software was used for protein identification and quantitation. Using the search engine Andromeda, mass spectrometry data were searched against the database containing UPS and E. coli proteins. MaxQuant reports summed intensity for each protein, as well as its iBAQ value. In the iBAQ algorithm, the intensities of the precursor peptides that map to each protein are summed together and divided by the number of theoretically observable peptides, which is considered to be all tryptic peptides between 6 and 30 amino acids in length. This operation converts a measure that is expected to be proportional to mass (intensity) into one that is proportional to molar amount (iBAQ). To determine relative molar abundances for each E. coli and human protein using MS1 data, two methods were used. In the first, we determined each proteins relative iBAQ (riBAQ), a normalized measure of molar abundance. We removed from the analysis all contaminant proteins that entered our sample-preparation workflow, for example keratins and trypsin, and then divided each remaining proteins iBAQ value by the sum of all non-contaminant iBAQ values. We also measured the average intensity of the three (or fewer, if fewer peptides were detected) peptides with the highest intensity, Top3, for each protein detected9. Peptides were chosen separately for each experiment, so the same peptides were not necessarily used across the four experiments. We generated a normalized \"top three\" abundance factor by dividing the average intensity for the three most abundant peptides of an individual protein and by the sum of all Top3 values in an experiment. Peptide intensities were summed for all charge states and variable modifications. For MS2 label-free analysis with MS2 spectra, MS2 data were searched against the database described above using SEQUEST. Setting to 1% the peptide false-discovery rate, estimated using a decoy (reversed) database, proteins were identified using the PAW pipeline. Normalized molar intensity (im) was calculated by dividing i, the summed intensity for an individual protein, by its molecular mass; the i/mr value for each protein was divided by the sum of all i/mr values. Normalized molar counts (cm) were calculated similarly, except the summed spectral counts for a protein (c) was used instead.

Dataset Information

Murine kidney glomeruli phosphorylation

Publications

Phosphoproteomic analysis reveals regulatory mechanisms at the kidney filtration barrier.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure